Quantcast
Last updated on April 18, 2014 at 12:39 EDT

Latest Anticonvulsant Stories

2014-01-22 12:26:32

$200,000 to be Awarded at 2014 Epilepsy Pipeline Update Conference in San Francisco June 5-7, 2014 LANDOVER, Md., Jan. 22, 2014 /PRNewswire-USNewswire/ -- The Epilepsy Foundation today announced a call for entries for the third annual epilepsy "Shark Tank" competition and is accepting submissions that represent the most innovative ideas in epilepsy and seizure treatment and care. The deadline for submitting a letter of intent is March 14, 2014. The selected finalists will receive...

2013-12-19 12:30:20

Responsive neurostimulator reduces frequency of seizures in patients with refractory epilepsy, shows potential to benefit millions around the globe LOS ANGELES, Dec. 19, 2013 /PRNewswire-USNewswire/ -- On Dec. 18, Keck Medicine of USC became the world's first medical center to implant a responsive brain device newly approved by the Food and Drug Administration (FDA) to treat epilepsy, with potential to help millions of people worldwide. The treatment involves surgical implantation...

2013-11-07 15:37:01

A recent prospective, randomized, placebo-controlled clinical trial reports that calcium and vitamin D supplementation improves bone density in a group of male veterans with epilepsy who were treated chronically with antiepileptic drugs (AEDs). The results published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggest that risedronate, a bisphosphonate, may help to prevent new vertebral fractures when taken with calcium and vitamin D supplementation. Many...

2013-09-24 10:16:27

Prenatal exposure to antiepileptic medications was associated with an increased risk of impaired fine motor skills (small muscle movements) in children at age 6 months, but breastfeeding by women taking the medications was not associated with any harmful effects on child development at ages 6 to 36 months, according to a report published by JAMA Neurology, a JAMA Network publication. Few studies have examined development during the first months of life of children of mothers with epilepsy,...

2013-09-18 04:22:35

LONDON, Sept. 18, 2013 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW") announced today it has commenced a Phase 1 clinical trial of product candidate GWP42006 for the treatment of epilepsy. Over the last five years, GW has conducted an extensive pre-clinical cannabinoid research program in the field of epilepsy in collaboration with the University of Reading in the United Kingdom. This research has led to the emergence of a number of promising cannabinoid...

2013-09-09 04:21:19

TAINAN, Sept. 9, 2013 /PRNewswire/ -- ScinoPharm Taiwan Ltd. (TSE: 1789.TW) announced that its Tainan, Taiwan Facility provides commercial manufacturing of topiramate active pharmaceutical ingredient ("API") for Trokendi XR(TM), a novel once-daily extended release formulation of topiramate for the treatment of epilepsy that was developed and recently launched by Supernus Pharmaceuticals in the U.S. market. Supernus received approval to market Trokendi XR(TM) by the United States...

Researchers Use Zebrafish To Reel In New Epilepsy Treatment
2013-09-03 15:36:39

Brett Smith for redOrbit.com - Your Universe Online The phrase ‘thinking outside the box’ has become so common these days, it’s almost thought of as an oxymoronic cliché. However, a group of University of California, San Francisco researchers, doing just that, may have stumbled onto a new drug to treat a certain form of childhood epilepsy. Although previous studies have found antihistamines can make seizures worse, the UCSF researchers found that the antihistamine clemizole can...

2013-08-20 20:21:20

DEA Delays Threaten to Hurt People Living with Seizures WASHINGTON, Aug. 20, 2013 /PRNewswire-USNewswire/ -- The Epilepsy Foundation calls on the Drug Enforcement Administration (DEA) to revise its process for reviewing new treatments. The current method dampens innovation and lacks transparency for both consumers and industry. Currently when a new treatment with abuse potential is approved by the Food and Drug Administration (FDA), the sponsors may not commercially market the drug...

Study Suggests Silky Brain Implants May Help Stop Spread Of Epilepsy
2013-07-25 12:04:43

NIH/National Institute of Neurological Disorders and Stroke NIH-funded study suggests role for adenosine in molecular processes involved in epilepsy Silk has walked straight off the runway and into the lab. According to a new study published in the Journal of Clinical Investigation, silk implants placed in the brain of laboratory animals and designed to release a specific chemical, adenosine, may help stop the progression of epilepsy. The research was supported by the National Institute...

Topiramate Treats Addiction
2013-07-19 09:37:32

Rebekah Eliason for redOrbit.com - Your Universe Online Topiramate is drug conventionally used to treat epilepsy and effect weight loss but it is currently being researched for its ability to help cocaine and alcohol addicts kick the habit. The results from this double-blind study offer hope that topiramate may help treat addiction. Several past studies have shown the drug to be effective for those addicted to either cocaine or alcohol, but no clinical trials have been performed on...